For questions, please email reimbursementsupport@quidelortho.com Rapid & Molecular Reimbursement Summary

Fee schedules do not reflect 2% Payment Adjustment (Sequestration). Click here for more information.

Rapid Diagnostics	Molecular Diagnostics	Cell Culture & Fluorescent Tests	ELISA
VITROS ECi/ECiQ	VITROS 350/XT 3400	VITROS 3600	VITROS 4600
	VITROS 5600	VITROS 7600
Please select your state:  National National ALABAMA ALASKA ARIZONA ARKANSAS CALIFORNIA COLORADO CONNECTICUT DELAWARE DIST of COL-DC + MD/VA Suburbs FLORIDA GEORGIA HAWAII IDAHO ILLINOIS INDIANA IOWA KANSAS KENTUCKY LOUISIANA MAINE MARYLAND MASSACHUSETTS MICHIGAN MINNESOTA MISSISSIPPI MISSOURI MONTANA NATIONAL LIMIT NEBRASKA NEVADA NEW HAMPSHIRE NEW JERSEY NEW MEXICO NEW YORK NORTH CAROLINA NORTH DAKOTA OHIO OKLAHOMA OREGON PENNSYLVANIA PUERTO RICO RHODE ISLAND SOUTH CAROLINA SOUTH DAKOTA TENNESSEE TEXAS UTAH VERMONT VIRGINIA WASHINGTON WEST VIRGINIA WISCONSIN WYOMING

Download this page as PDF

InflammaDry® Reimbursement Guidelines ABN-MMP9 Form	First Eye	83516-QW*		Immunoassay for analyte other than infectious agent antibody or infectious agent antigen; qualitative or semiquantitative, multiple step method	CCI   MUE	$ 11.53
	Second Eye	83516-QW+59*		Immunoassay for analyte other than infectious agent antibody or infectious agent antigen; qualitative or semiquantitative, multiple step method	CCI   MUE	$ 11.53
				If all tests are ordered, performed, and reported:		$ 23.06
QuickVue Adenoviral conjunctivitis Reimbursement Guidelines		87809-QW*	5834-7	Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; adenovirus	CCI   MUE	$ 21.76

Sofia® Influenza A+B FIA If practitioner orders results for both A and B: QW Effective/Implementation Dates Technical Bulletin	Influenza A	87400-QW*	72365-0	Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; Influenza, A or B, each	CCI   MUE	$ 14.13
	Influenza B	87400-QW+59*		Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; Influenza, A or B, each	CCI   MUE	$ 14.13
				If all tests are ordered, performed, and reported:		$ 28.26
QuickVue Influenza A+B If practitioner orders results for both A and B:	Influenza A	87804-QW*	72366-8	Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza	CCI   MUE	$ 16.55
	Influenza B	87804-QW+59*		Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza	CCI   MUE	$ 16.55
				If all tests are ordered, performed, and reported:		$ 33.10
Sofia® 2 Flu + SARS Antigen FIA QW Effective/Implementation Dates		87428-QW*	95942-9	Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; severe acute respiratory syndrome coronavirus (eg, SARS-CoV, SARS-CoV-2 [COVID-19]) and influenza virus types A and B	CCI   MUE	$ 70.29

For Medicare Clinical Laboratory Fee Schedule, go to www.cms.hhs.gov. *QW modifier is added to report use of CLIA-waived test system(s) for Medicare/Medicaid claims. CMS has set the effective date for the addition of the QW modifier with 87420 and 87430 as October 6, 2020 and an implementation date of July 6, 2021. That means Medicare/Medicaid have until July 6, 2021 to update their systems to accept the QW modifier with these codes. We recommend customers check with their payers prior to submitting claims to verify if their system has been updated. Effective January 1, 2010, CPT 81025 DOES NOT require a QW modifier to be recognized as a waived test. Source: CMS Job Aid 6685. This information is being provided as a reference, for informational purposes only, with no expressed or implied warranty and does not purport to provide legal or certified coding advice. Under Federal and State law, it is the individual provider's responsibility to determine appropriate coding, charges and claims for a particular service. Policies regarding appropriate coding and payment levels can vary greatly from payer to payer and change over time. Quidel Corporation strongly recommends that providers contact their contracted payers to determine appropriate coding and charge or payment levels prior to submitting claims. The information contained in this website has been compiled by CodeMap, L.L.C. who remains solely responsible for its content. The information provided is for general educational purposes only and may not be conclusive or exhaustive. Reimbursement information does not indicate overage for these services. While every effort is made to ensure that all payment amounts and regulatory information is current and complete, it is the responsibility of each user to verify specific coverage and payment information with their Medicare contractors. Actual reimbursement for healthcare facilities will vary depending on local carrier coverage and payment policies. Recent changes in applicable law, regulations and interpretations may not be reflected in the information contained herein. This website is a private website and is not associated, endorsed or authorized by the Department of Health and Human Services, the Center for Medicare and Medicaid Services or any other public or government organization or agency. CPT copyright 2023 American Medical Association. All rights reserved. This material contains content from LOINC (http://loinc.org). LOINC is copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license. LOINC® is a registered United States trademark of Regenstrief Institute, Inc. CodeMap® is a Registered Trademark of Wheaton Partners, LLC.

12/07/2024 04:05:51 18.97.14.81